SpanishDrug Discovery Network https://validator.w3.org/feed/docs/rss2.html Exhibitors and Sponsors Ponentes 2026 Laia Trigueros Motos From Concept to Application: High-Throughput Solubility and Aggregation Profiling in Drug Discovery with the ORYL F1 Platform. Development of a UHPLC-MS/MS Method for the Simultaneous Quantification of 18 Steroids to Expand the H295R Steroidogenesis Assay Posters – Information 2026 MBoIN179 targets the MCL1–BOK axis and reveals a potential therapeutic vulnerability in NSCLC Laura Saludas ALBA SYNCHROTRON: A CUTTING-EDGE RESOURCE FOR PHARMACEUTICAL COMPANIES Synergizing Multicellular Spheroids/Organoids, Microbial Natural Products, High Content Screening, and AI for Triple Negative Breast Cancer Therapy Discovery Metabolic Profiling of Tumor Organoids and Evaluation of Mitochondria-Targeting Anticancer Agents Using the Mito Tox Index A Short-Term Multi-Parametric Assay in Mice to Detect Early Phenotypic Changes of Longevity Interventions Preventing Hypothermia Through Oral Supplementation in Mice Annotated Sigma Receptor Ligand Library for Drug Discovery Sanj Kumar Fermin Goytisolo Jan Bober Transforming Drug Discovery: Generative Models and Electrostatic Complementarity Partnering Poster’s virtual room 2026 Programme2026 Home Exhibitors and Sponsors 2026 Description Innovative Bioluminescence Assays for Monitoring GPCR Dynamics: Advancing Therapeutic Strategies for Metabolic Disease Rewriting the Lysin Playbook: APEX®-engineered EPLETTX4 vs. Staphylococcus Photopharmacology for high precision drugs SIMChem: An Integrated Platform for Synthetic, Analytical, Photochemical and Biological Services Supporting Research and Innovation HIGH-THROUGHPUT 3D PHENOTYPIC SCREENING REVEALS NOVEL THERAPEUTIC OPPORTUNITIES IN PERITONEAL CARCINOMATOSIS AlphaScreen-Enabled Small Extracellular Vesicle Analysis Supports Hepatocellular Carcinoma Biomarker Detection, Patient Stratification, and Drug Discovery Leveraging conformational heterogeneity in proteins for drug discovery XVIII SDDN Meeting 2026 XVIII SDDN Meeting 2026 Sponsorship 2026 From our lab to a European library: bioprofiling our compounds through EU-OPENSCREEN TRANSLATING OMICS-DRIVEN DRUG REPURPOSING INTO EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE Rucaparib as a repurposed therapeutic strategy for Parkinson’s Disease: in vitro and in vivo validation. Uncovering Novel Therapeutic Candidates for Alzheimer’s Disease Through Integrative Omics-Based Drug Repurposing PROSPLIGN project: Prospecting Natural Lignin for Antitumor Activity: Unlocking the Potential of a Sustainable Biopolymer Vanessa Gómez Vallejo Franco Bernasconi Mariusz Milewski XVIII SDDN Meeting 2026 Juan Bautista Crespo García Ivan Cornella Taracido Jose Manuel Lopez Vilariño CARME PAMPIN JULIE MASSE Alba Mosteiro Couso Stefano Benvegnu Nicolas Tambucho